PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CBT vs. SPMO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CBT and SPMO is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

CBT vs. SPMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cabot Corporation (CBT) and Invesco S&P 500® Momentum ETF (SPMO). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
-3.15%
14.56%
CBT
SPMO

Key characteristics

Sharpe Ratio

CBT:

0.80

SPMO:

2.70

Sortino Ratio

CBT:

1.49

SPMO:

3.51

Omega Ratio

CBT:

1.18

SPMO:

1.47

Calmar Ratio

CBT:

1.01

SPMO:

3.78

Martin Ratio

CBT:

3.29

SPMO:

15.27

Ulcer Index

CBT:

7.89%

SPMO:

3.25%

Daily Std Dev

CBT:

32.56%

SPMO:

18.39%

Max Drawdown

CBT:

-82.87%

SPMO:

-30.95%

Current Drawdown

CBT:

-21.68%

SPMO:

0.00%

Returns By Period

In the year-to-date period, CBT achieves a -0.04% return, which is significantly lower than SPMO's 3.83% return.


CBT

YTD

-0.04%

1M

-3.90%

6M

-3.15%

1Y

24.35%

5Y*

18.13%

10Y*

10.91%

SPMO

YTD

3.83%

1M

4.81%

6M

14.56%

1Y

47.45%

5Y*

19.27%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CBT vs. SPMO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBT
The Risk-Adjusted Performance Rank of CBT is 7373
Overall Rank
The Sharpe Ratio Rank of CBT is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of CBT is 7171
Sortino Ratio Rank
The Omega Ratio Rank of CBT is 6868
Omega Ratio Rank
The Calmar Ratio Rank of CBT is 8080
Calmar Ratio Rank
The Martin Ratio Rank of CBT is 7474
Martin Ratio Rank

SPMO
The Risk-Adjusted Performance Rank of SPMO is 9090
Overall Rank
The Sharpe Ratio Rank of SPMO is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of SPMO is 9191
Sortino Ratio Rank
The Omega Ratio Rank of SPMO is 8989
Omega Ratio Rank
The Calmar Ratio Rank of SPMO is 8888
Calmar Ratio Rank
The Martin Ratio Rank of SPMO is 8888
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CBT vs. SPMO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cabot Corporation (CBT) and Invesco S&P 500® Momentum ETF (SPMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CBT, currently valued at 0.80, compared to the broader market-2.000.002.004.000.802.70
The chart of Sortino ratio for CBT, currently valued at 1.49, compared to the broader market-4.00-2.000.002.004.001.493.51
The chart of Omega ratio for CBT, currently valued at 1.18, compared to the broader market0.501.001.502.001.181.47
The chart of Calmar ratio for CBT, currently valued at 1.01, compared to the broader market0.002.004.006.001.013.78
The chart of Martin ratio for CBT, currently valued at 3.29, compared to the broader market-10.000.0010.0020.0030.003.2915.27
CBT
SPMO

The current CBT Sharpe Ratio is 0.80, which is lower than the SPMO Sharpe Ratio of 2.70. The chart below compares the historical Sharpe Ratios of CBT and SPMO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
0.80
2.70
CBT
SPMO

Dividends

CBT vs. SPMO - Dividend Comparison

CBT's dividend yield for the trailing twelve months is around 1.85%, more than SPMO's 0.46% yield.


TTM20242023202220212020201920182017201620152014
CBT
Cabot Corporation
1.85%1.85%1.88%2.21%2.53%3.12%2.90%3.04%2.02%2.22%2.68%1.96%
SPMO
Invesco S&P 500® Momentum ETF
0.46%0.48%1.63%1.66%0.52%1.27%1.39%1.05%0.77%1.94%0.36%0.00%

Drawdowns

CBT vs. SPMO - Drawdown Comparison

The maximum CBT drawdown since its inception was -82.87%, which is greater than SPMO's maximum drawdown of -30.95%. Use the drawdown chart below to compare losses from any high point for CBT and SPMO. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-21.68%
0
CBT
SPMO

Volatility

CBT vs. SPMO - Volatility Comparison

Cabot Corporation (CBT) has a higher volatility of 7.84% compared to Invesco S&P 500® Momentum ETF (SPMO) at 5.54%. This indicates that CBT's price experiences larger fluctuations and is considered to be riskier than SPMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
7.84%
5.54%
CBT
SPMO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab